Hepatic Medicine Evidence and Research

译名:肝脏医学:证据与研究

Hepatic Medicine-Evidence and Research

ESCIJCR Q3

1-3

2026

影响因子区间

平台估算

投稿周期

38%

2025

中国作者发文占比

2990 USD

费用说明

收费

期刊简介:Hepatic Medicine: Evidence and Research is an international, peer-reviewed, open access, online journal. Publishing original research, reports, editorials, reviews and commentaries on all aspects of adult and pediatric hepatology in the clinic and laboratory including the following topics: Pathology, pathophysiology of hepatic disease Investigation and treatment of hepatic disease Pharmacology of drugs used for the treatment of hepatic disease Although the main focus of the journal is to publish research and clinical results in humans; preclinical, animal and in vitro studies will be published where they will shed light on disease processes and potential new therapies. Issues of patient safety and quality of care will also be considered. Hepatic Medicine: Evidence and Research will no longer consider meta-analyses for publication.

【译文】《肝病医学:证据与研究》是一份国际同行评审、开放获取的在线期刊。在临床和实验室发表成人和儿童肝病学各个方面的原创研究、报告、社论、评论和评论,包括以下主题:肝病的病理学、病理生理学肝病的调查和治疗用于治疗肝病的药物的药理学虽然该杂志的主要重点是发表人类研究和临床结果;临床前、动物和体外研究将发表,这些研究将揭示疾病过程和潜在的新疗法。患者安全和护理质量问题也将得到考虑。肝病医学:证据与研究将不再考虑发表荟萃分析。

出版社
Dove Medical Press
语言
English
学科
医学
ISSN
1179-1535
eISSN
1179-1535
出版频率
年刊
创刊年份
1981
投稿网址
http://www.dovepress.com/hepatic-medicine-evidence-and-research-journal
最近更新
2026-04-02 18:16:40
Hepatic Medicine Evidence and Research

指标当前值近三年趋势
JCR分区Q3
暂无
影响因子区间1-3
暂无